Preschool Assessment of Preterm Infants Treated With Darbepoetin and Erythropoietin
Pediatrics, pp. 1-9, 2016.
BACKGROUND: We previously reported improved neurodevelopmental outcomes at 2 years among infants treated with the erythropoiesis-stimulating agents (ESAs) darbepoetin alfa (darbepoetin) or erythropoietin. Here we characterize 4-year outcomes. METHODS: Former preterm infants randomly assigned to receive darbepoetin (10 μg/kg, once per w...More
Full Text (Upload PDF)
PPT (Upload PPT)